PSNL - Personalis, Inc. Stock Analysis | Stock Taper
Logo

About Personalis, Inc.

https://www.personalis.com

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs.

Christopher M. Hall

CEO

Christopher M. Hall

Compensation Summary
(Year 2024)

Salary $587,500
Option Awards $522,460
Incentive Plan Pay $423,000
All Other Compensation $3,000
Total Compensation $1,535,960
Industry Medical - Diagnostics & Research
Sector Healthcare
Went public June 20, 2019
Method of going public IPO
Full time employees 228

ETFs Holding This Stock

Ratings Snapshot

Rating : C

Discounted Cash Flow 4
Return On Equity 1
Return On Assets 1
Debt To Equity 2
Price To Earnings 1
Price To Book 2
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Buy 4
Equal Weight 1

Showing Top 5 of 5

Price Target

Target High $11
Target Low $6
Target Median $10.5
Target Consensus $9.5

Institutional Ownership